Rotational atrophy of the choroid and retina (ROACR) is a rare, progressive degenerative disease characterized by irreversible changes in the structure and function of the choroid and retina. This condition can lead to vision loss due to insufficient blood supply and nutrition of the retinal neurons. ROACR is associated with various degenerative processes that affect the vascular structure and can be caused by genetic factors, infections, inflammatory diseases or other pathologies. The first manifestations of the disease may include flickering "flies" before the eyes, decreased visual acuity and the appearance of darkened areas in the visual field.
History of the disease and interesting historical facts
The history of the study of rotatory atrophy of the choroid and retina begins in the late 19th century, when leading ophthalmologists began recording cases of the disease and trying to identify its causes and consequences. The first clinical studies were conducted by scientists such as Karl Friedrich Zigmond and Rudolf Virchow, who drew attention to the connection between retinal atrophy and vascular disorders. An important step in understanding RWAC was the discovery of the possibility of a genetic predisposition, as well as the development of diagnostic methods such as fluorescein angiography. In the 20th century, increased awareness of the disease contributed to the establishment of specialized ophthalmological centers for the diagnosis and treatment of RWAC.
Epidemiology
The prevalence of rotatory atrophy of the choroid and retina is relatively low, but accurate data on incidence are often difficult due to a lack of awareness of the clinical manifestations of the disease. RACA is estimated to occur in 1-2% cases of general cardiovascular disease and may also be more common in patients with certain inherited syndromes. Variations in prevalence have been observed in different populations studied. Importantly, the risk of developing RACA increases with age, which is associated with the progression of vascular changes.
Genetic predisposition to this disease
Research suggests that choroidal and retinal rotatory atrophy may be associated with various genetic mutations. In particular, mutations in genes such as ABCA4, ELOVL4, and RPE65 have been linked to inherited eye disease that can lead to the development of VACC. These genes are responsible for functions related to the metabolism of visual pigments and the maintenance of retinal cell integrity. Patients with a family history of eye disease often have a higher risk of developing VACC, which confirms the importance of genetic diagnosis in identifying a predisposition to this condition.
Risk factors for the development of this disease
Risk factors associated with the development of rotatory atrophy of the choroid and retina can be divided into several categories:
- Physical factors: Age, prolonged sun exposure to the eye, exposure to certain medical procedures such as radiation therapy.
- Chemical factors: Exposure to toxic substances, especially chemicals used in the work environment or in the manufacture of certain medical products.
- Systemic diseases: Diabetes mellitus, hypertension, and systemic inflammatory diseases can worsen the condition of blood vessels.
- Hereditary factors: Presence of similar diseases in the family, previous diseases of the retina or choroid.
Diagnosis of this disease
Diagnosis of rotatory atrophy of the choroid and retina includes several stages:
- Main symptoms: Blurred vision, blind spots in the field of vision, distorted images.
- Laboratory tests: Ophthalmological tests, as well as tests for infectious and inflammatory processes.
- Radiological examinations: Ultrasound examination (US) of the eye and fluorescein angiography.
- Other types of diagnostics: Optical coherence tomography (OCT) for assessing the condition of the retinal layers.
- Differential diagnosis: Conditions such as diabetic retinopathy, glaucoma and other vascular diseases of the eye should be excluded.
Treatment
Treatment of rotatory atrophy of the choroid and retina depends on the stage of the disease and includes various approaches:
- General treatment: A healthy diet high in antioxidants and vitamins for the eyes.
- Pharmacological treatment: Use of anti-inflammatory drugs, as well as means to improve blood circulation in the eyes.
- Surgical treatment: In some cases, vitrectomy may be indicated to remove the cloudy vitreous.
- Other types of treatment: Laser therapy to restore blood supply to the retina.
List of medications used to treat this disease
Among the medications that can be prescribed for rotatory atrophy of the choroid and retina, the following can be distinguished:
- Diflucortolone (an anti-inflammatory drug).
- Latanovir (to improve blood supply).
- Drops with antioxidants (to protect retinal cells).
- Use of vitamins A, C and E.
Disease monitoring
Monitoring the patient's condition with rotatory atrophy of the choroid and retina includes regular ophthalmological examinations, assessment of visual acuity, and monitoring of changes in the visual field. It is important to establish a clear schedule of visits to the ophthalmologist to promptly identify possible complications and evaluate the effectiveness of therapy. The prognosis with early diagnosis can be favorable, but late stages often lead to serious visual impairment. Possible complications include retinal detachment, progression of atrophy, and complete loss of vision.
Age-related features of the disease
The course of rotatory atrophy of the choroid and retina depends differently on the age group:
- Children: Symptoms may be less pronounced, making diagnosis difficult. It is important to pay attention to heredity and undergo periodic examinations.
- Young people: More acute forms of the disease are often observed, requiring active intervention.
- Elderly people: In most cases, disease progression is associated with underlying health conditions such as diabetes or hypertension.
Questions and Answers
- What is rotatory atrophy of the choroid and retina? It is a disease characterized by degeneration of blood vessels and the retina, which can lead to deterioration or loss of vision.
- How is this disease diagnosed? Diagnosis is made using ophthalmological tests, laboratory tests, ultrasound and fluorescein angiography.
- What treatments are available for patients with VASS? Treatment may include drug therapy, surgery, and laser therapy.
- What is the role of heredity in the development of VASS? Hereditary factors play a significant role, as certain genes are associated with an increased risk of the disease.
- What do you need to know about VASS prevention? The most important preventive measures are health monitoring, regular check-ups and a healthy lifestyle.
Dr. Oleg Korzhikov advises patients suffering from rotatory atrophy of the choroid and retina to pay attention to their condition and not to ignore the first signs of vision deterioration. It is important to undergo regular examinations and not to forget about a healthy lifestyle, which includes balanced diets, physical activity and eye protection from ultraviolet radiation. He also emphasizes the need to inform loved ones about your diagnosis to ensure support during the treatment process.
